NanoMed North annual meeting no 3

Monday 8th of June, 2015, 16:00 – 19:00 at
Turning Torso, Lilla Varvsgatan 14, Malmö

16:00 – 16:25 Registration
16:30 – 18:00 Annual meeting
18:00 –      Antipasti buffé

Meeting agenda

1.    Opening
2.    Short presentation of annual meeting participants
3.    Information from the board about NMN
4.    Election of board members.
Proposal: re-election of Maria Kempe, Thomas Arnebrant and Agneta Richter Dahlfors. All for a period of two years.tt
5.    Other
6.    Presentations from members
Agneta Richter Dahlfors, Karolinska Institute
Börje Sellergren, Malmö University
Anja Boisen/Tomas Rindzevicius, Technical University of Denmark, DTU
7.    Closing of the meeting.

Please register for the meeting at info@nanomednorth.com as soon as possible but latest Friday May 29 – Thank you and most welcome!

We thank Turning Torso Meeting for selecting NanoMed North as one of ten prestigious networks to use the facility free of charge as a part of their ten year anniversary!

NanoMed North was one of the exhibitors at last week’s NanoForum in Stockholm. NanoForum is arranged by SwedNanoTech which is a nanotechnology network for both academia and industry in Sweden.

The “godfather” of nanotechnology; Eric Drexler was one of the keynote speakers and he gave a fascinating talk about advanced productive nanosystems. These nanosystems (nanoscale machinery) will according to Drexler have a large impact on for example life science industry in the future. If you want to know more about Eric Drexler´s work go to e-drexler.com.
“The Nanotechnology company of the yearaward” was presented at NanoForum. The award is handed out to a young, innovative Swedish nanotechnology company. This year’s nominees were: Cline Scientific, Exeger, Insplorin, Nanexa and Promimic. The award went to Exeger for their Dye-sensitized solar cells.

We had a lot of visitors at the NanoMed North stand and we give a warm welcome to our new members that signed up at NanoForum.

NMN-sthlmHanna Toftevall from GeccoDots. One of NanoMed North’s new members. GeccoDots is a nanotechnology company that work with multimodal contrast agents and biomarkers for medical imaging.

Niklas Holmquist, vice president of Cline Scientific, one of the nominated companies for the “Nanotechnology company of the year – award”. Cline Scientific are providing gradient surface technology to life science applications.

The CLINAM-Foundation and its collaborators for the conference have the pleasure to announce the European Summit for Clinical Nanomedicine and Targeted Medicine in Basel.

“The meeting has become a worldwide interdisciplinary Nanomedicine platform with 520 participants from 42 countries joining the last Summit in 2014. Its major goal is the support of development and application of Nanomedicine and Targeted Medicine to the benefit of the patient and humankind. The CLINAM Summit has achieved a unique position in bringing together all stakeholders relevant to the field of Nanomedicine and Targeted Medicine, including regulatory authorities from all continents, clinicians, researchers and industrial innovators from this area.” (CLINAM, European Foundation for Clinical Nanomedicine)

READ MORE on clinam.org
clinam

Welcome to CzechNanoDay

Thursday, March 19th, 2015
at The Czech Embassy in Stockholm, Villagatan 21, Stockholm
[divider_line]

Download the programme in PDF here
CzechNanoDay

International Society of Drug Delivery and Pharmaceutical Technology cordially invite you to the 1st European Conference

13 April to 14 April 2015 | Reims, France

With hot topic lectures on:

  • Drug Targeting
  • Liposomes and Nanoparticles
  • Oral Drug Delivery
  • Pulmonary Drug Delivery
  • Skin / Vaginal / Rectal / Nasal / Ear / Ocular Drug Delivery
  • Smart Drug Delivery Systems
  • Transdermal Drug Delivery
  • Vaccine Delivery

Go to the conference website!
Click here to download 1st announcement

banner

International Workshop on Multifunctional Nanotechnology for selective detection and treatment of cancer

This is an invitation to the Final International Workshop of the MULTIFUN project. This 3rd International Workshop on Multifunctional Nanotechnology for selective detection and treatment of cancer is a scientific event opened to both MultiFun and external researchers. The aim is to create a suitable environment to favour scientific interactions and discussions. In addition, we expect that this Final Workshop will promote and strengthen European and international research collaborations on different topics related to nanomedicine. Furthermore, the workshop will offer an exceptional opportunity to clinicians to get closer to some of the most exciting developments in the field.

These are the topics:

-Synthesis and characterization of organic and inorganic nanoparticles for biomedical applications (i.e. drug delivery, contrast signal, heating, sensing, etc.)
-Drug and gene delivery
-Hyperthermia mediated by nanoparticles for cancer treatment
-Contrast signal for cancer detection
-Modelling physico-chemical and biological properties of functionalized nanoparticles
-Cancer (stem) cell detection and elimination
-Novel and highly specific cancer (stem) cell markers
-Toxicology, biodistribution and biodegradation of functionalized nanoparticles

Go to registration to the Final MultiFun 2015 Workshop

Go to website for Multifun 2015 Workshop

The European Summit for Clinical Nanomedicne and Targeted Medicine. Basel, Switzerland

The Translation to Knowledge Based Nanomedicine.
8th Conference And Exhibition, June 28 – July 1, 2015

Sunday, June 28, 2015
• General Assembly of the European Society for Nanomedicine (15.30 h)
• Meeting of the International Society for Nanomedicine (16.30 h) • Editorial Board Meeting, European Journal of Nanomedicine (18.00 h)
• Welcome Dinner for Speakers & invited Guests [19.45 Swissôtel Le Plaza, 1st Floor]

Co-founded by the Swiss Confederation. Swiss Derpartment of Economic Affairs, Education and Research

Call for Papers and Posters

GO TO CLINAM WEBSITE

Scientific Committee: • Prof. Dr. med. Patrick Hunziker, University Hospital Basel (CH) (Chairman) • Prof. Dr. Yechezkel Barenholz, Hebrew University, Hadassah Medical School, Jerusalem (IL) • Beat Löffler, MA, European Foundation for Clinical Nanomedicine (CLINAM), Basel (CH) • Prof. Dr. Gert Storm, Institute for Pharmaceutical Sciences, Utrecht University, (NL) • Prof. Dr. Marisa Papaluca Amati, European Medicines Agency, London (GB) • Prof. Dr. med. Janos Szebeni, Bay Zoltan Ltd and Semmelweis/Miskolc Universities, Budapest (HU) • Prof. Dr. med. Christoph Alexiou, Head and Neck Surgery, University Hospital Erlangen (D) • Prof. Dr. Claus‐Michael Lehr, Helmholtz‐Institute for Pharmaceutical Research Saarland (HIPS), Saarbrucken (D) • Prof. Dr. Gerd Binnig, Founder of Definiens AG, Nobel Laureate, Munich (DE) Patrick Boisseau, CEA‐Léti, Chairman of the ETPN, Grenoble (FR) • Prof. Dr. Viola Vogel, Laboratory for Biologically Oriented Materials, ETH, Zürich (CH) • Prof. Dr. Jan Mollenhauer, Director Lundbeckfonden Center of Excellence University of Southern Denmark, Odense (DK) Dr. Yanay Ofran, Systems Biology & Functional Genomics, Bar Ilan University, Ramat Gan (IL)

Venue: Congress Center, Messeplatz 21, 4058 Basel, Switzerland, Phone + 41 58 206 28 28 info@congress.ch
Organizers Office: CLINAM‐Foundation, Alemannengasse 12, 4016 Basel Phone +41 61 695 93 95 clinam@clinam.org

Nanotechnology enables Personalized Medicine

Registration for the 6th International Congress – BioNanoMed 2015 is now open.
It’s an exclusive Know-How-Transfer meeting for scientists, researchers, engineers and practitioners from Natural Science, Medical Science and Engineering Subjects throughout the world.

The congress is organized in program tracks based on related technology topics.

Topics

A – Nanomaterials for Biomedical Applications & Regenerative Medicine
(supported by Erwin Schrödinger Society for Nanosciences)
B – Nanotechnology for Detection, Diagnostics, Therapeutics & Monitorings
C – NanoPharmaceuticals & Drug Delivery Nanotechnology
D – Advances in Nano-Oncology

Thematic Sessions

I – Bioinspired Nano-Technologies for Nanomedicine
II – Ethics and Societal Issues in Nanomedicine
(NanoDiode User Committee on Nanomedicine – co-organized by BioNanoNet GmbH)

Panel Discussion

Graz-Austria
Clinical Translation and Commercialization Aspects

Exhibition

BioNanoMed 2015 serves as an excellent platform to present your company/institution, to promote your product portfolio and to establish direct links to a broad audience of experts.

Poster Awards 2015 >> Info

Poster submissions will automatically participate in
Erwin Schrödinger Society Poster Award
and
Nano-Toxicology Award by BioNanoNet Forschungs GmbH

Important Dates

Deadline for oral abstracts: 8 January 2015
Deadline for poster abstracts: 18 March 2015
End of early registration: 31 January 2015
End of online registration: 3 April 2015

We are looking forward to your contributions!
[button size=”medium” align=”left” link=”http://www.bionanomed.at/index.php?id=26″ linkTarget=”_blank” bgColor=”#87001C” textColor=”#FFFFFF” hoverBgColor=”#FF6153″]Go to www.BioNanoMed[/button]

We would like to share this report with you:

“Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019
This report includes market estimations and forecast for nanomedicine products for the forecast period 2013 – 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 – 2019. The stakeholders for this report include present market players in the global nanomedicine market who aspire to increase their market share. Moreover, this report also targets the new players desiring to enter the global nanomedicine market.”

[button align=”left” link=”http://www.mynewsdesk.com/us/marketresearchreports-biz/pressreleases/nanomedicine-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-1082734?utm_source=alert&utm_medium=email&utm_campaign=Alert&utm_content” linkTarget=”_blank” bgColor=”#005077″ textColor=”#FFFFFF”]GO TO REPORT

Welcome to the 2nd European workshop on novel aspects of Nanomedicine entitled ”Nanomedicine Now – The Challenge to Translate Scientific Results to Applications for patients”.

Six years after the first Council of Europe workshop in Nanomedicine, the development of this important field has greatly advanced both in research and industry. The pharma-industry recognizes a market with high perspectives.

The hurdles to come from scientific findings to market with drugs and devices are identified: Characterization and toxicology of materials and drugs, the definition of side effects, biocompatibility and biodegradability of materials, production of particles in larger amounts, the principles of the translation, drug targeting strategies and the regulatory accreditation of products are the bang up-to-date challenges of the next years.

It took about 15 years to introduce Biotechnology to the large pharmaceutical companies; Nanomedicine is presently at the timeline to start-up due to the common interest of all stakeholders to advance in the field.

Novel apectsThe European Policy– and Decision-makers, European parliamentary members and experts in politics and government, but also scientists interested in the field, that have great interest for clearness, at what actual stage the development of this cutting edge field of medicine is.

The organizers of this meeting have invited highly recognized specialists to debate the current status quo and the expected perspectives for the next five years.

The workshop is a contribution to the expediting of the use of Nanomedicine to the benefit of the patients and again: Longer lasting health in age.

GO TO WEBSITE – Workshop on Novel aspects of Nanomedicine